Novel and potential therapy options for a range of cancer diseases: Using Flavonoid

Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These abnormal cells can form tumors or invade nearby tissues and organs, leading to a range of health problems. There are many different types of cancer, which can be categorized...

Full description

Saved in:
Bibliographic Details
Published inPathology, research and practice p. 154997
Main Authors Kadhum, Wesam R, Ramaiah, Pushpamala, Tayyib, Nahla A, Hjazi, Ahmed, Kahhharov, Alisher Jamoliddinovich, Alkhafaji, Adnan Taan, Al-Dami, Farqad Hassan, Ridha, Benien M, Alsalamy, Ali H, Alwave, Marim
Format Journal Article
LanguageEnglish
Published Germany 29.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These abnormal cells can form tumors or invade nearby tissues and organs, leading to a range of health problems. There are many different types of cancer, which can be categorized based on the location of the primary tumor, the type of cell involved, and the stage of the disease. Some common types of cancer include breast cancer, lung cancer, colon cancer, prostate cancer, and skin cancer. Nanoparticles are very small particles, typically ranging in size from 1 to 100 nanometers, that have unique physical and chemical properties. These properties make them attractive for use in a variety of applications, including cancer treatment. Flavonoids, which are natural compounds found in fruits, vegetables, and other plant-based foods, have been extensively studied for their potential role in cancer prevention and treatment. Flavonoids have been shown to possess a wide range of biological activities, including antioxidant, anti-inflammatory, anti-cancer, and anti-metastatic effects.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0344-0338
1618-0631
DOI:10.1016/j.prp.2023.154997